Navigation Links
Clinical Trial for the Treatment of Inflammatory Bowel Disease Begins at Tel Aviv Sourasky Medical Center
Date:7/21/2008

Anadis Ltd (ASX:ANX; OTC:ANDIY), a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel. The clinical trial will explore the efficacy of a formulation developed by Anadis to address the symptoms of Inflammatory Bowel Disease (IBD), a serious chronic condition effecting millions of persons annually.

MELBOURNE, Australia (Business Wire EON) July 21, 2008 -- About 4 million people worldwide suffer from Inflammatory Bowel Disease, split roughly evenly between the two manifestations of the disease: Crohn's disease (CD) and ulcerative colitis (UC). IBD is a relapsing / remitting chronic disease with gastrointestinal symptoms such as diarrhoea, rectal bleeding and abdominal pain.

The study is led by a leading Israeli Gastroenterologist, Professor Zamir Halpern, Deputy Director of Tel Aviv Sourasky Medical Center and Chief of the Center's Gastroenterology Institute, and by Professor Nachum Vaisman, Head of the Unit of Clinical Nutrition.

The first patients have already been recruited and have entered the trial which is expected be completed during 2009. The trial is designed as an open study being run to confirm and expand upon human clinical data obtained from a pilot study at St Vincent's Hospital in Melbourne, which ended recently. Anadis intends to launch its colostrum-derived product as a medical food or nutritional immediately following the Tel Aviv trial. Anadis will meet all regulatory requirements during the conduct of the trial itself.

In addition to the initiation of this IBD study, Anadis recently announced being awarded a VISTECH grant for another study, also to be conducted at Tel Aviv Souraski Medical Center, towar
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
2. North Carolinas Center For Advanced Medicine & Clinical Research Celebrates Opening of New LKN Medical Spa and Rejuvenation Center
3. Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
4. Northwestern Memorial Among Americas Best Hospitals in 10 Clinical Specialties According to U.S. News 2008 Rankings
5. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
6. Termination of IS Clinical From Distributing PhytoCeuticals Formulas
7. Dr. Howard Epstein Joins Blue Cross as Medical Director for Commercial Operations and Clinical Design
8. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
9. Clinical Launch of Innovative Cloth Sleep Apnea Mask Creates Buzz at Sleep Conference
10. New clinical trial for patients with asbestos-associated lung cancer
11. Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...30 SEIU Local 21LA memb...ation Sodexo will hold a rally Tuesday, Dec. 1, 20...eadquarters, 3800 Desire Parkway, New Orleans, to ... disciplinary policies that target employees who a...r. Sodexo employees who clean schools in the Recov...
(Date:11/30/2009)... Study Uses Tent To Simulate High Altitude, Low ...re-USNewswire/ -- Distance runners who live at hig...prove their performance during races in areas that...ho suffer from fatigue, improve their exercise per...simulator? ,, That is the question being studie...
(Date:11/30/2009)..., Nov. 30 The Eject Helmet Removal...d equipment in the Top Fuel, Funny Car, Pro Stock ...al Hot Rod Association (NHRA) Full Throttle Drag R...and Top Alcohol Funny Car drivers in the NHRA Luca...uct that allows medical caregivers at race tracks ...
(Date:11/30/2009)...2009 ― Providing free medications to people ...ves at a relatively low cost for provincial govern...St. Michael,s Hospital in Toronto. , "Many pati...medications because they simply don,t fill their p...lead author and a physician at St. Michael,s Hospi...
(Date:11/30/2009)...v. 30 Reportlinker.com announces t...ts catalogue: ,, Key Players and Innovative St...ingredients, pharma, food and drinks ,, http:...novative-Start-Ups-in-Nutraceuticals-Emerging-stra... ,, Nutraceuticals are bioactive compounds with...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6
... Finally, the world,s first complete intimacy kit... With all the concerns about STDs being plastered ... leave it to a company called "Safe & Cle...l 9, 2009 -- The world,s first complete intimacy k...
... 8 Today, the U.S. Food and Drug Administration (...(PDAC) conducted a review of the safety and effica...r SEROQUEL XR (quetiapine fumarate) extended-relea...: , , , SEROQUEL XR was shown to be eff...
... programs for delivering optimum value and custome...90% of the nation,s nonprofit academic medical cen...lutions, a leader in delivering healthcare resourc...ated hospitals, representing approximately 90% of ...
...predominance of heartburn among asthma sufferers l...uld be a trigger for the coughing, wheezing and br...ndard practice to prescribe heartburn medication t...l without significant heartburn shows that heartbu...
...l 8 The following was released today by the Ameri...ts have suffered a severe blow in the last week. ...s to redefine marriage and in so doing has jeopard... statement that, "The traditional notion that chil...
...nknown in adults, revs up calorie-burning, experts...s) -- Take note of the brown revolution -- the bro...ups of scientists on two continents have independe...sue is metabolically active and the more of this f...
Other Medicine News:Health News:The World's First Complete Intimacy Kit for Safe and Clean Sex 2Health News:The World's First Complete Intimacy Kit for Safe and Clean Sex 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 2Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 3Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 4Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 5Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 6Health News:FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications 7Health News:University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum 2Health News:University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum 3Health News:Heartburn medications do not ease asthma symptoms 2Health News:Heartburn medications do not ease asthma symptoms 3Health News:A Fat That May Keep You Thin 2Health News:A Fat That May Keep You Thin 3
(Date:11/30/2009)...Newswire/ -- Amoena USA Corporation, the worldwide...ponsoring the 4th Annual Breast Cancer Survivors C...nor survivors and the people who helped them throu...with the most inspirational story to tell. ,, A...young mothers who bravely endured treatments; wome...
(Date:11/30/2009)..., November 30 Optoacoustics has an...nnel microphone, the most advanced,optical microph...ance imaging,(fMRI) environments. , The t...ard for fiber,optic microphone technology, providi...ncy adaptive noise cancelling. The FOMRI-III also ...
(Date:11/30/2009)... Intelliject, Inc. today announced... a novel epinephrine auto-injector, in the U.S. an...tis U.S. shall be responsible for manufacturing an...le for the on-going development and for obtaining ...co-promotion rights in the territory. ,, Sanofi...
Breaking Medicine Technology:Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Prix Galien USA Announces 2009 Final Candidates 13441 1Prix Galien USA Announces 2009 Final Candidates 13441 2Cleveland Joins Navvis 26amp 3B Company 53927 1Cleveland Joins Navvis 26amp 3B Company 53927 2Guided care reduces cost of health care for older persons with chronic conditions 53925 1Guided care reduces cost of health care for older persons with chronic conditions 53925 2
...ia Pharmaceuticals presented,positive results toda...onal,HIV protease inhibitor (PI). One study based ... of interaction of SPI-256 with HIV protease,provi...tic barrier to,resistance. The second study conduc...6 is generally safe and well tolerated in humans a...
...harmaceuticals, Inc. today,announced positive Phas...96, a first-in-class aminomethylcycline (AMC). The...l and intravenous (IV) forms of PTK 0796 to,Zyvox(...kin and skin,structure infections (cSSSIs). Parate...endpoint, demonstrating no differences between PTK...
Other Medicine Technology:Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 2Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 3Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor 4Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4
...800 is an individually configurable System for dec...e identification via cap recognition is optional) ... clearly organized workflow. The input and output ...ty. The System can simply be loaded with various t...
...mbination of the Aliquoting System RSD 800A with a... turns out in an efficient System and a complete s...all important front-end and back-end features: cen...ation, sample quality control, decapping, barcode ...
...SD 800A is an individually configurable System for...itional tube type identification via cap recogniti...ample tubes in a clearly organized workflow. The i...ffer high capacity. The System can simply be loade...
...00 can sort different specimen in one run. Complex...more and all samples are sorted, decapped and arch... after being given sorting priorities. Optionally ...a Decapping Module can be integrated. Selectively ...
Medicine Products: